These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16475263)

  • 1. [Infections and lymphoma during prolonged immunosuppression in vascular diseases].
    Guillevin L
    Rev Med Interne; 2005 Oct; 26 Spec No 1():35-8. PubMed ID: 16475263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anakinra for therapy of rheumatoid arthritis].
    Tomoo T; Sumida T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
    [No Abstract]   [Full Text] [Related]  

  • 3. Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy.
    Schoffelen T; Kampschreur LM; van Roeden SE; Wever PC; den Broeder AA; Nabuurs-Franssen MH; Sprong T; Joosten LA; van Riel PL; Oosterheert JJ; van Deuren M; Creemers MC
    Ann Rheum Dis; 2014 Jul; 73(7):1436-8. PubMed ID: 24794150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)].
    Manger B;
    Z Rheumatol; 2002 Dec; 61(6):698-700. PubMed ID: 12491134
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary immune deficiencies associated with biological therapeutics.
    Lee SJ; Yedla P; Kavanaugh A
    Curr Allergy Asthma Rep; 2003 Sep; 3(5):389-95. PubMed ID: 12906774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hair changes in immunosuppressive therapy].
    Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J
    Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of benefit/risk of biological agents.
    Imperato AK; Bingham CO; Abramson SB
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S108-14. PubMed ID: 15552523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trials of anakinra.
    Burls A; Jobanputra P
    Lancet; 2004 Sep 4-10; 364(9437):827-8. PubMed ID: 15351176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infections during antirheumatic treatment].
    Kneitz C
    Dtsch Med Wochenschr; 2014 Aug; 139(31-32):1593-5. PubMed ID: 25076314
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii2-ii12. PubMed ID: 15479866
    [No Abstract]   [Full Text] [Related]  

  • 12. Serious infections associated with anticytokine therapies in the rheumatic diseases.
    Giles JT; Bathon JM
    J Intensive Care Med; 2004; 19(6):320-34. PubMed ID: 15523118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for rheumatoid arthritis.
    Olsen NJ; Stein CM
    N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
    [No Abstract]   [Full Text] [Related]  

  • 14. [The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis].
    Riente L
    Reumatismo; 2004; 56(1 Suppl 1):74-9. PubMed ID: 15201943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra shows promise for treating patients with rheumatoid arthritis.
    McIntosh T; Freeman TR
    J Am Pharm Assoc (Wash); 2002; 42(4):660-2. PubMed ID: 12150367
    [No Abstract]   [Full Text] [Related]  

  • 16. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
    Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
    CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1RA in refractory systemic lupus erythematosus.
    Moosig F; Zeuner R; Renk C; Schröder JO
    Lupus; 2004; 13(8):605-6. PubMed ID: 15462491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma, rheumatoid arthritis, and TNFalpha antagonists.
    Mariette X
    Joint Bone Spine; 2010 May; 77(3):195-7. PubMed ID: 20399132
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
    Seitz M
    Ther Umsch; 2002 Oct; 59(10):535-43. PubMed ID: 12428439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports].
    Söderlin M; Blomkvist C; Dahl P; Forsberg P; Fohlman J
    Lakartidningen; 2005 Dec 5-11; 102(49):3794-6, 3799-800. PubMed ID: 16408703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.